OHSU, Spinout Najit, and WUSTL to Co-Develop West Nile Vaccine Using $7.3M NIAID Grant

As owner of the underlying platform technology, Oregon Health and Science University stands to benefit financially if Najit can successfully market a vaccine for West Nile virus or any other infectious disease.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register quickly here for free access.